Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Freedman

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|December 22, 1999
Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovaryB A Werness, A N Freedman, M S Piver, et al.
Journal of General Internal Medicine|January 5, 2006
The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Results from the National Health Interview SurveyC P Gross, G Filardo, H S Singh, et al.
Journal of Medical Genetics|March 24, 2005
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physiciansL Wideroff, S T Vadaparampil, M H Greene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survivalS Kayastha, A N Freedman, M S Piver, et al.
American Journal of Epidemiology|May 15, 1996
Gravid health status, medication use, and risk of neuroblastomaA M Michalek, G M Buck, P C Nasca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2013
Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analysesJ P A Ioannidis, Y Zhou, C Q Chang, et al.
Carcinogenesis|April 1, 1997
Oral contraceptives, reproductive factors and p53 gene expression in colorectal cancerA N Freedman, A M Michalek, R Troisi, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 30, 2013
Expression of p27(Kip1) and bcl-2, cigarette smoking, and colorectal cancer riskN Ishibe, A N Freedman, A M Michalek, et al.
Breast Cancer Research and Treatment|January 29, 2014
Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based studyH-T Tsai, C Isaacs, A Z Fu, et al.
American Journal of Medical Genetics. Part A|June 10, 2003
US physicians' attitudes toward genetic testing for cancer susceptibilityA N Freedman, L Wideroff, L Olson, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|December 22, 1999
Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovaryB A Werness, A N Freedman, M S Piver, et al.
Journal of General Internal Medicine|January 5, 2006
The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Results from the National Health Interview SurveyC P Gross, G Filardo, H S Singh, et al.
Journal of Medical Genetics|March 24, 2005
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physiciansL Wideroff, S T Vadaparampil, M H Greene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survivalS Kayastha, A N Freedman, M S Piver, et al.
American Journal of Epidemiology|May 15, 1996
Gravid health status, medication use, and risk of neuroblastomaA M Michalek, G M Buck, P C Nasca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2013
Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analysesJ P A Ioannidis, Y Zhou, C Q Chang, et al.
Carcinogenesis|April 1, 1997
Oral contraceptives, reproductive factors and p53 gene expression in colorectal cancerA N Freedman, A M Michalek, R Troisi, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 30, 2013
Expression of p27(Kip1) and bcl-2, cigarette smoking, and colorectal cancer riskN Ishibe, A N Freedman, A M Michalek, et al.
Breast Cancer Research and Treatment|January 29, 2014
Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based studyH-T Tsai, C Isaacs, A Z Fu, et al.
American Journal of Medical Genetics. Part A|June 10, 2003
US physicians' attitudes toward genetic testing for cancer susceptibilityA N Freedman, L Wideroff, L Olson, et al.
Pageof 3